calcipotriol/betamethasone dipropionate / Generic mfg.  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

17 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
calcipotriol/betamethasone dipropionate / Generic mfg.
NCT01052467: Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)

Completed
N/A
724
Europe
Xamiol® Gel
LEO Pharma
Scalp Psoriasis
05/10
05/10
NCT01320774: Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

Completed
N/A
588
Europe
Daivobet® Gel
LEO Pharma, LEO Pharma GmbH, Neu-Isenburg, Germany
Psoriasis Vulgaris
01/12
01/12
NCT01413477: Nickel Desensitization Using Topical Therapy

Unknown status
N/A
24
Canada
Calcipotriol, Betamethasone, Calcipotriol & Betamethasone, Dovonex (calcipotriol ointment, DIN 01976133 Leo Pharma),, Dovobet (DIN 02244126, Leo Pharma), Betamethasone diproprionate (0.5% ointment USP generic)
University of British Columbia
Allergic Contact Dermatitis
02/12
06/12
ChiCTR-TRC-12002447: clinical demonstration research of

Completed
N/A
40
 
PSORI-CMO1 decoction plus Calcipotriol Betamethasone Ointment ;Placebo decoction plus Betamethasone Ointment
Guangdong Provincial Hospital of Chinese Medicine; Guangdong Provincial Hospital of Chinese Medicine, The Ministry of Science and Technology
psoriasis vulgaris
 
 
NCT01233583 / 2010-019129-32: Regulatory T-cells in Psoriasis Patients as Targets for Therapy

Completed
N/A
38
Europe
Dovobet, neotigason, etanercept, adalimumab. infliximab
University of Aberdeen, NHS Grampian
Psoriasis
09/13
09/13
NCT01982552: An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life

Completed
N/A
147
US
LEO Pharma
Psoriasis Vulgaris
01/14
01/14
NCT01707368: Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation

Completed
N/A
561
Europe
Daivobet® Gel
LEO Pharma
Psoriasis Vulgaris, Plaque Psoriasis
05/14
07/14
NCT02191007: Efficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to Psoriasis

Completed
N/A
230
RoW
Calcipotriol Betamethasone ointment and Calcipotriol ointment, Calcipotriol Betamethasone ointment, Calcipotriol Betamethasone ointment and Urea Cream
Xijing Hospital
Psoriasis
05/14
05/14
NCT02489643: Individualized Medical Training and Calcipotriol and Betamethasone Dipropionate Gel in Plaque Psoriasis

Completed
N/A
60
Europe
Individualized practical training
Catholic University of the Sacred Heart
Psoriasis
05/15
 
ASAP PSO, NCT02856542: Real-life Evaluation of the Daivobet® Gel Applicator

Completed
N/A
1560
Europe
calcipotriol/betamethasone dipropionate gel in Applicator, Daivobet® gel Applicator
LEO Pharma
Plaque Psoriasis
06/17
06/17
ChiCTR-TRC-13003233: Clinical study according to pathogenesis treatment for psoriasis vulgaris

Completed
N/A
600
 
PSORI-CM 01 granules+ Calcipotriol Betamethasone and Calcipotriol Ointment ;Placebo granules + Calcipotriol Betamethasone and Calcipotriol Ointment
Guangdong Provincial Hospital of Chinese Medicine; Guangdong Provincial Hospital of Chinese Medicine, The Ministry of Scinece and Technology, China
psoriasis
 
 
BODYGUARD, NCT02636101: Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study

Completed
N/A
603
RoW
Calcipotriol/betamethasone dipropionate gel, Xamiol®, Daivobet®
LEO Pharma
Psoriasis Vulgaris
02/18
02/18
NCT06327620: Treatment Of Oral Lichen Planus

Recruiting
N/A
15
RoW
Daivobet ointment, topical steroids
Mansoura University
Lichen Planus
05/24
05/24
ChiCTR2100043944: Single-blind, prospective, self-controlled efficacy and safety observation of calcipotriol betamethasone topical preparation combined with 595nm pulsed dye laser and single calcipotriol betamethasone topical preparation for treatment of nail psoriasis

Recruiting
N/A
30
 
calcipotriol betamethasone topical preparations alone and combined with 595nm pulsed dye laser
West China Hospital of Sichuan University; West China Hospital of Sichuan University, None
Nail psoriasis
 
 
NCT06011083: Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis

Completed
N/A
40
RoW
Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm, Fractional carbon dioxide (CO2) laser
Assiut University
Psoriasis Vulgaris, Fractional CO2 Laser
02/23
08/23
NBUVB, NCT04440371: Phototherapy Combination With Topicals in Vitiligo

Active, not recruiting
N/A
40
RoW
Tacrolimus 0.1% ointment twice daily plus NBUVB 3 times weekly, Calcipotriol/Betamethasone ointment plus NBUVB
Jordan University of Science and Technology
Vitiligo, Generalized
07/23
12/23
PRO-SCALP, NCT05811234: A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults

Active, not recruiting
N/A
291
Europe
CAL/BDP PAD Cream, Wynzora®
Almirall, S.A.
Plaque Psoriasis
08/24
08/24

Download Options